[Optimizing the management of bladder cancer in older patients].

AIM To define and present potential improvements for the management of bladder cancer in older patients. METHOD Bibliographical search was performed from the Medline bibliographic database (NLM Pubmed tool) and Embase focused on: bladder cancer, treatment, BCG, chemotherapy, cystectomy, and elderly. RESULTS The oncological principles of medico-surgical management of bladder cancer do not differ according to age. On the other hand, the patient comorbidities have been likely to alter the tolerance of these treatments. At the NMIBC stages, no adaptation of the standard treatment has demonstrated any interest. At the MIBC stages, the prognosis was improved by geriatric multidisciplinary perioperative management. CONCLUSION The indications and principles of surgical treatments must be identical regardless of the patient age. At the NMIBC stages, adjuvant therapy, including BCG therapy, should not be questioned because of the age of the patient. On the other hand, at the localized MIBC stages, neoadjuvant and adjuvant chemotherapy should not be considered as a standard and their indications assessed individually after geriatric assessment.

• Publication year

  2019

• Venue

  Progrès en urologie (Paris)

• Publication date

  2019-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.purol.2019.08.273PMID 31771768
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Contemporary trends of pelvic lymph node dissection at radical cystectomy for urothelial carcinoma of urinary bladder and associated cancer specific mortality and complications: comparison between octogenarian versus younger patients.

  2019cited by this paper
• In-Hospital Outcomes after Radical Cystectomy for Bladder Cancer: Comparing National Trends in the United States and Germany from 2006 to 2014

  2019cited by this paper
• Curative radiation therapy for very elderly bladder cancer patients with localized disease

  2018cited by this paper
• Curative Treatment for Muscle Invasive Bladder Cancer in Elderly Patients: A Systematic Review.

  2018cited by this paper
• Superior efficacy of neoadjuvant chemotherapy and radical cystectomy in cT3‐4aN0M0 compared to cT2N0M0 bladder cancer

  2018cited by this paper
• Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial.

  2018cited by this paper
• Value of an Immediate Intravesical Instillation of Mitomycin C in Patients with Non-muscle-invasive Bladder Cancer: A Prospective Multicentre Randomised Study in 2243 patients.

  2018cited by this paper
• Predicting Response to Intravesical Bacillus Calmette-Guérin Immunotherapy: Are We There Yet? A Systematic Review.

  2018cited by this paper
• Recommandations françaises du Comité de Cancérologie de l’AFU – Actualisation 2018–2020 : tumeurs de la vessie

  2018cited by this paper
• Cystectomy for bladder cancer in elderly patients is not associated with increased 30- and 90-day mortality or readmission, length of stay, and cost: propensity score matching using a population database

  2018cited by this paper
• Accelerated Hypofractionated Radiation Therapy for Elderly Frail Bladder Cancer Patients Unfit for Surgery or Chemotherapy

  2018cited by this paper
• RETRACTED: Recommandations françaises du Comité de Cancérologie de l’AFU — Actualisation 2018—2020 : tumeurs de la vessie

  2018cited by this paper
• Sarcopenia predicts 90-day mortality and postoperative complications after radical cystectomy for bladder cancer

  2018cited by this paper
• Impact of age on outcomes of patients with non-muscle-invasive bladder cancer treated with immediate postoperative instillation of mitomycin C.

  2018cited by this paper
• A systematic review and meta-analysis on the oncological long-term outcomes after trimodality therapy and radical cystectomy with or without neoadjuvant chemotherapy for muscle-invasive bladder cancer.

  2017cited by this paper
• Risks and benefits of pelvic lymphadenectomy in octogenarians undergoing radical cystectomy due to urothelial carcinoma of the bladder

  2017cited by this paper
• Comparative Perioperative Outcomes in Septuagenarians and Octogenarians Undergoing Radical Cystectomy for Bladder Cancer-Do Outcomes Differ?

  2017cited by this paper
• Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial.

  2017cited by this paper
• Impact of suboptimal neoadjuvant chemotherapy on peri‐operative outcomes and survival after robot‐assisted radical cystectomy: a multicentre multinational study

  2017cited by this paper
• Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience.

  2017cited by this paper
• Radical cystectomy or bladder preservation with radiochemotherapy in elderly patients with muscle-invasive bladder cancer: Retrospective International Study of Cancers of the Urothelial Tract (RISC) Investigators

  2017cited by this paper
• Vigorous intensity aerobic interval exercise in bladder cancer patients prior to radical cystectomy: a feasibility randomised controlled trial

  2017cited by this paper
• Pembrolizumab as Second‐Line Therapy for Advanced Urothelial Carcinoma

  2017cited by this paper
• Ten-Year Review of Perioperative Complications After Transurethral Resection of Bladder Tumors: Analysis of Monopolar and Plasmakinetic Bipolar Cases

  2017cited by this paper
• Chemoradiotherapy in octogenarians as primary treatment for muscle-invasive bladder cancer.

  2017cited by this paper
• Clinical Outcomes of Image Guided Adaptive Hypofractionated Weekly Radiation Therapy for Bladder Cancer in Patients Unsuitable for Radical Treatment

  2017cited by this paper
• Safety and activity of pembrolizumab in patients with locally advanced or metastatic urothelial cancer (KEYNOTE-012): a non-randomised, open-label, phase 1b study.

  2017cited by this paper
• Concurrent chemotherapy is associated with improved survival in elderly patients with bladder cancer undergoing radiotherapy

  2017cited by this paper
• Outcome of Transurethral Resection of Bladder Tumor: Does Antiplatelet Therapy Really Matter? Analysis of a Retrospective Series

  2017cited by this paper
• Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial.

  2017cited by this paper
• Considerations for successful cancer immunotherapy in aged hosts

  2017cited by this paper
• Radical cystectomy in the elderly – Is this a safe treatment option?

  2017cited by this paper
• First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study.

  2017cited by this paper
• Neoadjuvant Chemotherapy in Elderly Patients With Bladder Cancer: Oncologic Outcomes From a Single Institution Experience

  2017cited by this paper
• Nivolumab monotherapy in recurrent metastatic urothelial carcinoma (CheckMate 032): a multicentre, open-label, phase 1/2 trial

  2016cited by this paper
• Exercise-based pre-habilitation is feasible and effective in radical cystectomy pathways—secondary results from a randomized controlled trial

  2016cited by this paper
• Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial.

  2016cited by this paper
• Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: A Systematic Review and Two-Step Meta-Analysis.

  2016cited by this paper
• Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa-pT1 Urothelial Carcinoma of the Bladder: Which Patients Benefit from

  2016cited by this paper
• MUSCLE-INVASIVE AND METASTATIC BLADDER CANCER

  2016cited by this paper
• Comparing the Efficiency and Safety of Bipolar and Monopolar Transurethral Resection for Non-Muscle Invasive Bladder Tumors: A Systematic Review and Meta-Analysis

  2016cited by this paper
• Safety and Efficacy of Durvalumab (MEDI4736), an Anti-Programmed Cell Death Ligand-1 Immune Checkpoint Inhibitor, in Patients With Advanced Urothelial Bladder Cancer.

  2016cited by this paper
• Radical cystectomy versus organ-sparing trimodality treatment in muscle-invasive bladder cancer: A systematic review of clinical trials.

  2015cited by this paper
• Bladder cancer in the elderly patient: challenges and solutions

  2015cited by this paper
• Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3-pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial.

  2015cited by this paper
• Radical trimodality therapy for patients with locally advanced bladder cancer: The British Columbia Cancer Agency experience.

  2015cited by this paper
• Screening for Vulnerability in Older Cancer Patients: The ONCODAGE Prospective Multicenter Cohort Study

  2014cited by this paper
• A systematic review and meta-analysis of adjuvant and neoadjuvant chemotherapy for upper tract urothelial carcinoma.

  2014cited by this paper
• The effect of age on the efficacy of maintenance bacillus Calmette-Guérin relative to maintenance epirubicin in patients with stage Ta T1 urothelial bladder cancer: results from EORTC genito-urinary group study 30911.

  2014cited by this paper
• Factores predictores de recidiva en el tumor vesical primario Ta de bajo grado

  2014cited by this paper
• EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines.

  2014cited by this paper
• Trimodality Therapy for Bladder Preservation in the Elderly Population with Invasive Bladder Cancer

  2014cited by this paper
• Monopolar versus bipolar transurethral resection of bladder tumors: a single center, parallel arm, randomized, controlled trial.

  2014cited by this paper
• Transuretral resection of the bladder (TURB): analysis of complications using a modified Clavien system in an Italian real life cohort.

  2014cited by this paper
• Urinary bladder cancer treated with radical cystectomy: Perioperative parameters and early complications prospectively registered in a national population-based database

  2014cited by this paper
• Predicting factors for recurrence in low-grade Ta primary bladder tumours.

  2014cited by this paper
• Comparison of perioperative outcomes including severe bladder injury between monopolar and bipolar transurethral resection of bladder tumors: a population based comparison.

  2014cited by this paper
• Prospective, open-label, randomized, phase III study of two dose-dense regimens MVAC versus gemcitabine/cisplatin in patients with inoperable, metastatic or relapsed urothelial cancer: a Hellenic Cooperative Oncology Group study (HE 16/03).

  2013cited by this paper
• Plasmakinetic bipolar versus monopolar transurethral resection of non‐muscle invasive bladder cancer: A single center randomized controlled trial

  2013cited by this paper
• Ureterostomia cutânea como opção de derivação urinária em pacientes em condições clínicas após cistectomia radical

  2013cited by this paper
• Cutaneous ureterostomy with definitive ureteral stent as urinary diversion option in unfit patients after radical cystectomy.

  2013cited by this paper
• Signatures of mutational processes in human cancer

  2013cited by this paper
• Randomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC study 30986.

  2012cited by this paper
• Adjuvant chemotherapy with cisplatin and gemcitabine versus chemotherapy at relapse in patients with muscle-invasive bladder cancer submitted to radical cystectomy: an Italian, multicenter, randomized phase III trial.

  2012cited by this paper
• Randomized phase III study comparing paclitaxel/cisplatin/gemcitabine and gemcitabine/cisplatin in patients with locally advanced or metastatic urothelial cancer without prior systemic therapy: EORTC Intergroup Study 30987.

  2012cited by this paper
• The blockade of immune checkpoints in cancer immunotherapy

  2012cited by this paper
• Gender and body mass index as risk factors for bladder perforation during primary transurethral resection of bladder tumors.

  2012cited by this paper
• Narrow band imaging cystoscopy and bipolar plasma vaporization for large nonmuscle-invasive bladder tumors--results of a prospective, randomized comparison to the standard approach.

  2012cited by this paper
• Perioperative platelet inhibition in transurethral interventions: TURP/TURB.

  2012cited by this paper
• Over 500 obturator nerve blocks in the lithotomy position during transurethral resection of bladder tumor

  2012cited by this paper
• International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial.

  2011cited by this paper
• The Z‐shaped ileal neobladder after radical cystectomy: an 18 years experience with 329 patients

  2011cited by this paper
• Complications associated with urinary diversion

  2011cited by this paper
• Comprehensive geriatric assessment in the decision-making process in elderly patients with cancer: ELCAPA study.

  2011cited by this paper
• Predicting the probability of 90-day survival of elderly patients with bladder cancer treated with radical cystectomy.

  2011cited by this paper
• Determining factors for hospital discharge status after radical cystectomy in a large contemporary cohort.

  2011cited by this paper
• Comparison of the success rate of inguinal approach with classical pubic approach for obturator nerve block in patients undergoing TURB

  2011cited by this paper
• Transurethral resection of bladder tumour complicated by perforation requiring open surgical repair – clinical characteristics and oncological outcomes

  2011cited by this paper
• Immunity, cancer and aging: lessons from mouse models.

  2011cited by this paper
• Comparative kinetic analyses of gene profiles of naïve CD4+ and CD8+ T cells from young and old animals reveal novel age‐related alterations

  2011cited by this paper
• Diminished efficacy of Bacille Calmette-Guérin among elderly patients with nonmuscle invasive bladder cancer.

  2011cited by this paper
• Randomized phase III trial of 2nd line gemcitabine and paclitaxel chemotherapy in patients with advanced bladder cancer: short-term versus prolonged treatment [German Association of Urological Oncology (AUO) trial AB 20/99].

  2011cited by this paper
• The importance of pelvic lymph node dissection in the elderly population: implications for interpreting the 2010 National Comprehensive Cancer Network practice guidelines for bladder cancer treatment.

  2011cited by this paper
• Could patient age influence tumor recurrence rate in non-muscle-invasive bladder cancer patients treated with BCG immunotherapy?

  2011cited by this paper
• Managing muscle-invasive bladder cancer in the elderly

  2010cited by this paper
• Comparing the Safety and Efficiency of Conventional Monopolar, Plasmakinetic, and Holmium Laser Transurethral Resection of Primary Non-muscle Invasive Bladder Cancer

  2010cited by this paper
• Anemia and transfusions in geriatric patients: a time for evaluation

  2010cited by this paper
• Percutaneous urinary drainage and ureteric stenting in malignant disease.

  2010cited by this paper
• Radical Cystectomy for Bladder Cancer in the 70+ Population: A Nation-Wide Registry Analysis of 845 Patients

  2010cited by this paper
• Perioperative mortality is significantly greater in septuagenarian and octogenarian patients treated with radical cystectomy for urothelial carcinoma of the bladder.

  2010cited by this paper
• Quality of life and body image for bladder cancer patients undergoing radical cystectomy and urinary diversion--a prospective cohort study with a systematic review of literature.

  2009cited by this paper
• Bladder cancer in the elderly.

  2009cited by this paper
• The impact of lymphadenectomy and lymph node metastasis on the outcomes of radical cystectomy for bladder cancer.

  2009cited by this paper
• Assessment and Interpretation of Comorbidity Burden in Older Adults with Cancer

  2009cited by this paper
• Is it the patient or the physician who cannot tolerate anemia? A prospective analysis in 1854 non-transfused coronary artery surgery patients

  2009cited by this paper
• Evaluation of the Incidence of Bladder Perforation After Transurethral Bladder Tumor Resection in a Residency Setting

  2009cited by this paper
• Mortality increases when radical cystectomy is delayed more than 12 weeks

  2009cited by this paper
• Prognostic model for predicting survival after palliative urinary diversion for ureteral obstruction: analysis of 140 cases.

  2008cited by this paper
• Comparison of complications in three incontinent urinary diversions.

  2008cited by this paper
• Effect of advanced age on the development of complications from intravesical bacillus Calmette-Guérin therapy.

  2008cited by this paper

• Derivaciones urinarias no continentes

  2025cites this paper
• Management of Bladder Tumors: What Results in 10 Years of Practice at the University Clinic of Urology-Andrology of the CNHU-HKM of Cotonou?

  2025cites this paper
• Interest of the POSPOM score in estimating post-operative complication risk after radical cystectomy.

  2024cites this paper
• Dérivations urinaires non continentes

  2024cites this paper
• [Geriatric assessment and treatment of nonmetastatic muscle-invasive bladder cancer in patients over 75 years of age. Retrospective and multicentric study of 121 cases].

  2022cites this paper